Introduction
In the last decade, positron emission tomography (PET) imaging became one of the most beneficial and accurate diagnostic tools in oncological diagnosis. Especially when combined with computed tomography (PET/CT), its accuracy in imaging malignant tissue increases up to 93% compared to PET scan only (78-85%) [1, 2] . There are many reports confirming its utility in patients with lymphoma, lung cancer, breast cancer, colorectal cancer and liver metastases, oesophageal cancer, head and neck tumours, and melanoma as well as tumours of unknown origin [3] [4] [5] [6] [7] [8] [9] [10] . The role of PET in thyroid cancer management has been widely described. It should be routinely performed in patients previously treated for well-differentiated (follicular or papillary) thyroid cancer when the whole-body scan performed with radioiodine is negative and the thyroglobulin is markedly elevated [11] .
Rafał Czepczyński et al., PET thyroid incidentalomas Original Apart from this situation, PET/CT may contribute to visualization of additional findings that were not the indication to the study and did not refer to initial diagnosis. About 1-2% of such incidental findings localize in the thyroid gland [12] [13] [14] [15] . Significantly increased 18 F-fluorodeoxyglucose ( 18 FDG) uptake in these patients still seems not to be clarified. As sufficient data is missing, fine needle aspiration biopsy still remains conclusive in the final diagnosis.
Aim of the study
The purpose of the study was to assess the prevalence and evaluate the clinical significance of incidental thyroid 18 F-FDG uptake in a cohort of patients diagnosed for other malignancies.
Material and methods
PET/CT scans using 18 Diffused 18F-FDG activity in both thyroid lobes was observed in 120 subjects (6.2%). Patients presenting diffused 18 F-FDG uptake in the thyroid were suspected of autoimmune thyroid disease that was then confirmed in laboratory findings (elevated serum thyroid antibodies) and characteristic hormonal and clinical status. These patients were not evaluated in the current study. 
Original Discussion
Our study seems to confirm previous studies conducted in other centres. The prevalence of incidental focally increased 18 F-FDG metabolism ranges, depending on study cohort, from 1.0% to 4.3% [16, 17] . In the biggest retrospective study devel- higher SUV max values in malignant than in benign lesions, estimating SUV max above 8 as a strong predictor of malignancy. In other studies, the highest SUV max of malignant thyroid lesions was also significantly higher than that of benign lesions [23] . A significant correlation between SUV max and maximal diameter of the thyroid incidentaloma was also found [24] . However, it has also been demonstrated that low SUV max in a thyroid focus does not exclude malignancy. Other authors concluded no significant difference in SUV max between benign and malignant nodules [19, 25] . In ano- All 18 FDG-avid nodules were confirmed to be cancers (100%), while almost 39% of benign lesions appeared to present increased 18 F-FDG uptake. In our study only one out of 4 patients with previous inconclusive FNAB result was diagnosed with follicular adenoma in histopathological examination. Currently, data is being collected to analyze whether PET/CT is helpful in decreasing the amount of unnecessary thyroidectomies due to inconclusive cytological findings.
Distant metastases that locate in the thyroid gland are rather rare. Occasionally, some of the malignant lesions found in thyroid with the means of PET/CT appear to be metastatic [30] . These data are confirmed in our study population of oncological patients: only one focus of an extrathyroid origin was detected -it was a metastasis of non-small cell lung carcinoma.
In 6.2% of our patients diffused thyroid uptake of 18F-FDG was found. The most likely diagnosis is chronic thyroiditis. In fact, many of these patients had already been treated with Lthyroxin before performing the scan. Although diffused 18 F-FDG uptake seems to be quite accurate in confirming the diagnosis of Hashimoto thyroiditis [19, 21] , a risk of thyroid cancer in both diffuse and combined 18 F-FDG uptake should be kept in mind [18, 22] . Additionally, the presence of Hashimoto disease with a large goitre may impair the diagnostic value of 18 FDG PET in primary thyroid lymphoma [20] . Therefore, thyroid FNAB seems to be obligatory in cases of coexisting diffused 18 F-FDG uptake in PET scans and the occurrence of lesions seen in thyroid sonography. In our study FNAB results were available only in a few cases of diffused 18 FDG uptake; all of them reported Hashimoto thyroiditis.
Conclusions
The probability of malignancy in the case of focal 18 F-FDG accumulation in the thyroid gland is rather high. Therefore, thorough evaluation of such lesions is highly recommended in each case.
Most thyroid malignancies incidentally detected in PET/CT are papillary carcinomas.
